All Cosmos Bio-Tech Holding Corporation reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was TWD 2,197.32 million compared to TWD 1,642.78 million a year ago. Revenue was TWD 2,197.32 million compared to TWD 1,642.78 million a year ago.

Net income was TWD 198.13 million compared to TWD 82.2 million a year ago. Basic earnings per share from continuing operations was TWD 3.09 compared to TWD 1.28 a year ago. Diluted earnings per share from continuing operations was TWD 3.09 compared to TWD 1.28 a year ago.